PUREGON 300 IU/0.36 ml, solution for injection cartridge, 0.48 ml

Telegram WhatsApp

Link to share

Active ingredients: FOLLITROPINE BÊTA

Commercialized according to BDPMDispensing in France: Prescription only

Solution for injectioncartridge, 0.48 mlsous-cutanée

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: PUREGON 300 UI/0,36 ml, solution injectable
Pharmaceutical form: solution injectable
Route of administration: sous-cutanée
Presentation description: 1 cartouche(s) en verre de 0,48 ml avec 6 aiguille(s)
Marketing authorisation holder: ORGANON (HOLLANDE)
Reimbursement according to BDPM: 100%
Approval for use in healthcare institutions: oui
Commercialization declaration date: 11 Apr 2002
Prescription and dispensing conditions: Prescription only
List I: prescription-only medicine
Requires special monitoring during treatment
Prescribed by specialists only
Original BDPM wording: liste I · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ENDOCRINOLOGIE · prescription réservée aux spécialistes et services GYNECOLOGIE · prescription réservée aux spécialistes et services MALADIES METABOLIQUES · prescription réservée aux spécialistes et services OBSTETRIQUE · prescription réservée aux spécialistes et services UROLOGIE
Enhanced ANSM monitoring: No

BDPM identifiers

CIS62448341CIP73530974CIP133400935309747

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
FOLLITROPINE BÊTAsolution	400 UI · une cartouche	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.